Owing to the intricacies associated with the manufacturing processes, requirement of advanced production facilities and the growing demand for cell therapy products, developers are actively outsourcing certain manufacturing operations and automation technologies, in addition to expanding their in-house capabilities.

The financial opportunity associated with cell therapy manufacturing market has been analyzed across the following segments:

§  Type of Cell Therapy

§  T cell therapies

§  Dendritic cell therapies

§  NK cell therapies

§  Stem cell therapies

§  Source of Cell

§  Autologous

§  Allogeneic

§  Scale of Operation

§  Clinical

§  Commercial

§  Purpose of Manufacturing

§  In-house Manufacturing

§  Contract Manufacturing

§  Geographical Regions

§  North America

§  Europe

§  Asia Pacific

• Rest of the World 

The Cell Therapy Manufacturing Market (5th Edition), 2022-2035 report features the following companies, which we identified to be key players in this domain:

§  AGC Biologics

§  BioNTech Innovative Manufacturing Services

§  Cell and Gene Therapy Catapult

§  Cell Therapies

§  Center for Cell and Gene Therapy, Baylor College of Medicine

§  Center for Cell Manufacturing Ireland, National University of Ireland

§  Charles River Laboratories

§  Clinical Cell and Vaccine Production Facility, University of Pennsylvania

§  FUJIFILM Cellular Dynamics

§  Guy’s and St. Thomas GMP Facility, Guy’s Hospital

§  KBI Biopharma

§  Laboratory for Cell and Gene Medicine, Stanford University

§  Lonza

§  MEDINET

§  Minaris Regenerative Medicine

§  Molecular and Cellular Therapeutics, University of Minnesota

§  Newcastle Cellular Therapies Facility, Newcastle University

§  Nikon CeLL innovation

§  Rayne Cell Therapy Suite, King’s College London

§  RoslinCT

§  Scottish National Blood Transfusion Service, Scottish Centre of Regenerative Medicine

§  Sydney Cell and Gene Therapy

§  Thermofisher Scientific

§  WuXi AppTec

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Market Overview

5. Regulatory Landscape

6. Roadmaps for Overcoming Challenges

7. Automation Technologies for Cell Therapies Manufacturing 

8. Profiles: Industry Players

9. Profiles: Non-Industry Players

10. Role of Non-Profit Organizations

11. Clinical Trial Analysis

12. Partnerships and Collaborations

13. Recent Expansions

14. Big Pharma Initiatives

15. Capacity Analysis

16. Demand Analysis

17. Cost Price Analysis

18. Make Versus Buy Decision Making Framework

19. Total Cost of Ownership

20. Market Sizing and Opportunity Analysis

21. Key Insights

22. SWOT Analysis

23. Concluding Remarks

24. Survey Analysis

25. Interview Transcripts

26. Appendix 1: Tabulated Data

27. Appendix 2: List of Companies and Organizations

To view more details on this report, click on the link:

https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html

Learn from experts:  do you know about these emerging industry trends?

Deep Learning-based Interoperability: Advanced Neural Networks Mimicking the Human Brain

Novel Cell Cytometers: Need of the Hour

Learn from our recently published whitepaper: -

Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services: 

Roots Analysis Consulting - the preferred research partner for global firms

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com